Axel Hauschild
University Hospital Schleswig-Holstein
ORCID: 0000-0002-1212-9587Also affiliated with University of Lübeck
Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Why this DataRank?
An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.
Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.
Read the full methodology →Papers
Driven by 3 papers. Top paper: “Biomarker results from a phase II study of MEK1/2 inhibitor binimetinib (MEK162) in patients with advancedNRAS- orBRAF-mutated melanoma”.
Sanjiv S. Agarwala, Axel Hauschild, Carola Berking, J. Thaddeus Beck, Dirk Schadendorf +12 more
Roman C. Maron, Achim Hekler, Jochen Utikal, Catarina Barata, Raymond L. Barnhill +60 more
Alan C. Geller, A. Stergiopoulou, Niki Dimou, Serigne Lo, Ulrike Keim +17 more